Fulgent Genetics announces annual shareholder meeting

Fulgent Genetics, Inc. -0.49%

Fulgent Genetics, Inc.

FLGT

16.18

-0.49%

  • Fulgent Genetics scheduled 2026 annual stockholder meeting in El Monte, California on May 14, 2026.
  • Shareholders will vote on election of four directors for one-year terms ending in 2027.
  • Ballot includes ratification of Deloitte & Touche as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Advisory vote set on executive compensation.
  • Meeting will also consider approval of 2026 Equity Incentive Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulgent Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001674930-26-000020), on March 31, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.